Rehoboth, MA, United States of America

Gerhard Andrew Foelsche

This inventor holds 13 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Kimberly-Clark Worldwide, Inc., Axogen Corporation, Cvs Pharmacy, Inc. a Rhode Island Corporation. Active years: 2003-2025.

USPTO Granted Patents = 13 

% Patents Active = 76.9

 

 

Average Co-Inventor Count = 4.3

ph-index = 5

Forward Citations = 111(Granted Patents)


Location History:

  • Neenah, WI (US) (2017)
  • Rehoboth, MA (US) (2003 - 2024)

Company Filing History:


Years Active: 2003-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Mind of Gerhard Andrew Foelsche

Introduction:

Gerhard Andrew Foelsche, a talented inventor based in Rehoboth, MA (US), is known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents:

Foelsche's latest patents include a cutting-edge smart home automation system that revolutionizes the way we interact with our living spaces, and a unique wearable device that enhances communication for individuals with hearing impairments.

Career Highlights:

With a career spanning over two decades, Foelsche has established himself as a visionary in the tech industry. His work has been instrumental in shaping the future of smart technology and accessibility devices.

Collaborations:

Foelsche has collaborated with leading tech companies and research institutions to bring his inventions to life. His partnerships have led to the development of products that have improved the quality of life for many individuals around the world.

Conclusion:

In conclusion, Gerhard Andrew Foelsche's innovative spirit and dedication to creating cutting-edge solutions have solidified his reputation as a pioneering inventor in the field of technology. His passion for pushing the boundaries of what is possible continues to inspire others in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…